Capital Fund Management S.A. Biogen Inc. Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

A detailed history of Capital Fund Management S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 93,224 shares of BIIB stock, worth $18.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

93,224

Previous 147,430 36.77%

Holding current value

$18.1 Million

Previous $31.8 Million 32.02%

% of portfolio

0.06%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $10.3 Million - $12.8 Million	-54,206 Reduced 36.77%	93,224 $21.6 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $31.3 Million - $39.5 Million	147,430 New	147,430 $31.8 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $3.66 Million - $4.44 Million	-14,492 Reduced 45.4%	17,431 $4.83 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $6.22 Million - $8.57 Million	31,923 New	31,923 $8.52 Billion
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $833,206 - $1.07 Million	3,721 Added 18.58%	23,743 $5.7 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $5.67 Million - $7.39 Million	20,022 New	20,022 $5.67 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $13.1 Million - $19.7 Million	-55,464 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $13.3 Million - $15.4 Million	-50,239 Reduced 47.53%	55,464 $15.7 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $4.32 Million - $5.72 Million	16,703 Added 18.77%	105,703 $28.3 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $5.67 Million - $7.19 Million	-21,091 Reduced 19.16%	89,000 $28.2 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $5.19 Million - $7.18 Million	23,604 Added 27.29%	110,091 $32.7 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $1.59 Million - $1.78 Million	7,294 Added 9.21%	86,487 $20.1 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $7.58 Million - $8.35 Million	34,548 Added 77.38%	79,193 $18.5 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $8.09 Million - $12.6 Million	37,318 Added 509.32%	44,645 $10.6 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $27.4 Million - $34.7 Million	-98,440 Reduced 93.07%	7,327 $2.21 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $19.8 Million - $23.6 Million	76,902 Added 266.42%	105,767 $30.7 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $7.51 Million - $10.6 Million	28,865 New	28,865 $7.9 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Biogen Inc. Transaction History